Français
ItalianoBond Bausch Health Group 11% ( USC07885AL76 ) in USD
| Issuer | Bausch Health Group |
| Market price |  105.608 % ▲ |
| Country |  Canada
|
| ISIN code |
 USC07885AL76 ( in USD )
|
| Interest rate | 11% per year ( payment 2 times a year) |
| Maturity | 30/09/2028 |
|
Prospectus brochure in PDF format is unavailable at this time We will provide it as soon as possible |
|
| Minimal amount | 1 000 USD |
| Total amount | 1 774 067 000 USD |
| Cusip | C07885AL7 |
| Standard & Poor's ( S&P ) rating | B- ( Highly speculative ) |
| Moody's rating | Caa1 ( Substantial risks ) |
| Next Coupon | 30/03/2026 ( In 144 days ) |
| Detailed description |
Bausch Health Companies is a global pharmaceutical company focused on developing, manufacturing, and marketing a range of pharmaceutical, ophthalmological, and consumer healthcare products. Bausch Health Companies (USD) 11% bonds due September 30, 2028 (CUSIP: C07885AL7, ISIN: USC07885AL76), with a total issuance size of $1,774,067,000 and a minimum purchase size of $1,000, are currently trading at 91.24% of par value, paying semi-annually, and rated B- by S&P and Caa1 by Moody's. |